Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • LAGroh
    Junior Member
    • Sep 2013
    • 2

    #1

    Adapter primer design issues, and why phosphorothioate bonds?

    Hi, our group is performing a population study of stem niche succession in colorectal crypts; not too interesting for you guys. However this does mean that we will have some 300 unique samples though, so in our library prep we would like to attach barcodes to both the front and the back of our amplicons to reduce the number from 300 unique primers to 30, and since the ligation kits are really expensive we’re planning to also include the A adapter and the P1 sequence into our primers as well. The issue is, we were given sequences from the sequencing department here in the hospital, but they don't seem to match any of the literature. Below are the sequences. P1 B comp appears to be the compliment of P1 A but with the odd addition of “*T*T” at the 3’ end (presumably “in” the DNA amplicon :S ).


    P1 A: 5'-CCACTACGCCTCCGCTTTCCTCTCTATGGGCAGTCGGTGAT-3'

    P1 B "comp": 5'-ATCACCGACTGCCCATAGAGAGGAAAGCGGAGGCGTAGTGG*T*T-3’

    Lit: 5' -CCTCTCTATGGGCAGTCGGTGAT- 3'

    * = phosphorothioate bonds.

    Interestingly, the red section is the same sequence as the sequences found in literature. So my question is, which sequence should I use to design my reverse primer (also let me know if I should use the complimentary strand to any of these sequences)?
    The P1 A and P1 B sequences seem to be the same sequences used in the KAPA Adapter Kits technical data sheet, which doesn’t provide much information on why things are used and unfortunately I can’t find much other information on this kit otherwise.

    Also I read that phosphorothioate bonds prevent the degradation by exonucleases, but I have a hard time figuring out when my DNA will be exposed to exonucleases during the sequenceing procedure. Just to keep an eye on the costs, would it be possible/recommended to do without them?
  • jwfoley
    Senior Member
    • Jun 2009
    • 183

    #2
    since the ligation kits are really expensive we’re planning to also include the A adapter and the P1 sequence into our primers as well.
    A certain popular ligation kit is a ridiculous waste of money because it's just a regular ligation kit with PEG added to the buffer, but at any rate, if you can build adapters into your primers and avoid ligation, that's an improvement for non-cost reasons too: ligation reduces your yield and library complexity. (So does any unnecessary step, but especially ligation since it's intermolecular and low-efficiency.)

    The issue is, we were given sequences from the sequencing department here in the hospital, but they don't seem to match any of the literature.
    I don't recognize them either - maybe you could specify what sequencing platform they're for?

    Also I read that phosphorothioate bonds prevent the degradation by exonucleases, but I have a hard time figuring out when my DNA will be exposed to exonucleases during the sequenceing procedure. Just to keep an eye on the costs, would it be possible/recommended to do without them?
    They're there for a reason and the cost is negligible. The exonuclease is actually the 3'->5' exo activity of the polymerase (which is what gives it its fidelity); you don't want your polymerase chewing up your primers instead of synthesizing off them. But it basically can't digest thiolated DNA. Then why do you need more than one phosphorothioate? Because when you synthesize the oligo, you get a racemic mixture of one enantiomer that stops exonucleases and one enantiomer that doesn't. So with 50-50 odds of a useless phosphorothioate at each of two positions, there's only a 25% chance that any given molecule is vulnerable to exonuclease digestion.

    Comment

    • LAGroh
      Junior Member
      • Sep 2013
      • 2

      #3
      Originally posted by jwfoley View Post
      I don't recognize them either - maybe you could specify what sequencing platform they're for?
      Ahem... Yes I could see why that would be important. We're going to use Ion Torrent PGM.
      Sorry for whatever reason I thought I was in the PGM section!

      Originally posted by jwfoley View Post
      They're there for a reason and the cost is negligible. The exonuclease is actually the 3'->5' exo activity of the polymerase (which is what gives it its fidelity); you don't want your polymerase chewing up your primers instead of synthesizing off them. But it basically can't digest thiolated DNA. Then why do you need more than one phosphorothioate? Because when you synthesize the oligo, you get a racemic mixture of one enantiomer that stops exonucleases and one enantiomer that doesn't. So with 50-50 odds of a useless phosphorothioate at each of two positions, there's only a 25% chance that any given molecule is vulnerable to exonuclease digestion.
      Ok thanks that makes sense. Strange how I haven't been able to read this anywhere in the manuals :S

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
        by SEQadmin2



        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

        Despite this, “CRISPR helped turn genome editing from a specialized technique into
        ...
        07-31-2026, 11:01 AM
      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 08-06-2026, 07:41 AM
      0 responses
      17 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-03-2026, 10:13 AM
      0 responses
      33 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-31-2026, 02:55 AM
      0 responses
      42 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      26 views
      0 reactions
      Last Post SEQadmin2  
      Working...